InsiderTradr

InMode Ltd. (INMD)

NasdaqGS · USD · Healthcare · Medical Devices

$13.72 (-1.79%) as of

Key statistics

Market cap
789.51M
P/E (TTM)
11.34
Forward P/E
10.00
EPS (TTM)
1.21
Dividend yield
0.00%
52-week range
12.72 – 16.67
Beta
2.03
Revenue (TTM)
374.62M
Profit margin
20.69%
Analyst target
$16.17
Volume
644.28k

About InMode Ltd.

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. It offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. The company also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions. In addition, it offers hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company sells and markets its products in the United States, Canada, the United Kingdom, Ireland, Spain, Portugal, France, Belgium, Luxemburg, Italy, Germany, Austria, Japan, Australia, and India through distributors. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. The company was incorporated in 2008 and is headquartered in Yokne'am, Israel.

Sector
Healthcare
Industry
Medical Devices
Headquarters
Yokne'am, Israel
Employees
660

inmodemd.com

Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.

Related stocks